William New

William New

  • Articles: 1217
  • Comments: 43

Tedros Warms Up To Press In First Meeting, Sees Clear Mandate In “Landslide” Victory

In his first meeting with the United Nations press corps the morning after his historic election as the next director general of the World Health Organization, Tedros Adhanom Ghebreyesus began to unfold his vision for the organisation and fended off questions about the United States budget by saying WHO has to diversify its funding base. He also signaled a variety of possible issues to come such as increased assessments on governments, and consideration of the recommendations of a recent UN report on access to medicines.

Speculation Rampant In Leadup To WHO Director General Election Today

Speculation in the hallways of United Nations headquarters in Geneva was rampant in the days and hours leading up to this afternoon’s election of a new director general to lead the UN World Health Organization, but solid information about who will win was hard to come by. The outcome after a series votes is expected sometime tonight.
Update! According to sources, the first round of voting is over. Results: Tedros 95, Nabarro 52, Nishtar 38. Second round update! Tedros 121, Nabarro 62. Third round underway.

US Renegotiation Of NAFTA To Include IP Rights, Digital Trade

Newly confirmed United States Trade Representative Robert Lighthizer issued a letter to Congress today stating that he will lead a renegotiation of the 1994 North American Free Trade Agreement (NAFTA) with Canada and Mexico. And the changes will include new provisions on intellectual property rights and digital trade.

WHO, Stakeholders Take ‘First Step’ On Fair Pricing For Medicines

The World Health Organization has concluded a major one-day forum on fair pricing of medicines, bringing a wide range of stakeholders together in Amsterdam and coming up with several possible actions for the way ahead. Key points of discussion included a definition of fair pricing, moving away from value-based pricing, delinkage of price from research and development costs, and greater transparency, according to participants.

The True Believer: An Interview With New IFPMA Director General Thomas Cueni

The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) has long been at the centre of global public health policy in Geneva, representing industry from around the world. Now at a critical moment of change in the policymaking machinery, a new leader, Thomas Cueni of Switzerland, has taken over. Intellectual Property Watch recently sat down with him to discuss his views and vision going forward, and discovered his intellectual pragmatism and diverse experience which promise to open an ambitious new era for the association and global health policy.